善得定诱导卡铂腹腔淋巴化疗的实验研究

汪邵平; 王强; 王元和; 李全业

善得定诱导卡铂腹腔淋巴化疗的实验研究

1. 广州军区广州总医院普外科,510010;2. 第二军医大学长征医院普外科,510010

详细信息

中图分类号: R730.5
计量
- 文章访问数: 874
- HTML全文浏览量: 25
- PDF下载量: 239
出版历程
- 刊出日期: 1998-10-04

Sandostatin modulation of lymphatic drug exposure following intraperitoneal administration of carboplatin

Wang shaopin¹,

The general militory hospital of guang zhou,Guangzhou 510010

摘要

摘要: 为探讨善得定对腹腔化疗中淋巴药物浓度的影响,对16只兔腹腔注入卡铂50mg十生理盐水100ml,实验组加用善得定,分取门静脉血、外周血、淋巴液,应用原子吸收光谱法测定样本铂浓度.结果显示:实验组淋巴铂浓度达峰后可维持较高水平,其药-时曲线下面积(AUC)显著增加.外周血铂浓度却下降明显.提示:在卡铂腹腔化疗中应用善得定能提高化疗药物在淋巴中的作用效能,达到诱导腹腔淋巴化疗的目的.同时又可进-步减轻化疗药物的全身毒副反应.
- 善得定 /
- 卡铂 /
- 腹腔化疗 /
- 淋巴化疗
Abstract: To examine the effect of sandostatin to lymph drug concntration following intraperitoneal(IP)chemotherapy,50mg carboplat was injected into Rabbits IP along with 20ug/h sandostatin as a continous Ⅳ infusion in one group and no sandostatin in the control group.The platinum in lym-ph,jugular vein and protal vein over the ensuring 8 hous were measured by the flameless atomic abshaption spectoscopy.The result show:for the experimental whinals,the Platinum in lymph remain a higher level even after reaching the peak concenhation,result in the increasing of AUC(0- 8)(P<0.01).In contrast,it kept on decreasing in jugular vein(P<0.01).This Permitted an indirect estimate of the effect of sand-ostatin on the rate of carboplatin movement from the peritoneal cavity to the local lymph,so become the candidate to induce intra-abdominal lymphatic chemotherapy with more lower system reaction.
- carboplatin /
- sandostatin /
- intraperitoneal chemotherapy /
- lymphatic chemotherapy

HTML全文

参考文献(7)

1. Dedrick RL,Myers CE,Bungary DM,et al.Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.Canc-er Treat Rep,1978,62:1.

2. Markman M.Intraperitoneal chemotherapy.Semin oncol.1991,18:248.

3. Linder P,Health DD,Shalinsky DR,et al.Re-gional lymphatic drug exposure following intraperitoneal administation of 5-Fluorouracil,carboplatin and etoposide.Surg oncol,1993,2:105.

4. 张荣河,齐春莲.胃癌的淋巴化疗.国外医学肿瘤分册,1993,20:12.

5. 孙念绪,马宏敏,詹新恩,等.胃肠肿瘤化疗途径进展.普外临床,1996,11(1):15.

6. Wahren J,Eriksson LS.The influence of a long-acting Somatostatin analogue,on the splanchnic Haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.Scand J Gastr,1986,21(sup119):103.

7. Smith SP,Solomon TE.Effects of gastrin,progglumide and somatosatin on growth of huamn colon cancer.Gastroenterology,1988,95:1541